How should a left pleural effusion be evaluated and managed?

Evaluation and Management of Left Pleural Effusion

Begin with clinical assessment and chest radiography to determine if the effusion is likely transudative (heart failure, cirrhosis, hypoalbuminemia), and if so, treat the underlying cause without sampling unless atypical features exist or the effusion fails to respond to therapy. 1

Initial Clinical Assessment

History and Physical Examination:

• Document medication history specifically for tyrosine kinase inhibitors and other drugs causing exudative effusions 1
• Obtain detailed occupational history including asbestos exposure 1
• Assess for pleuritic pain (present in ~75% of pulmonary embolism cases with effusion) 1
• Evaluate dyspnea severity relative to effusion size (disproportionate dyspnea suggests pulmonary embolism) 1
• Look for signs of heart failure, liver disease, or renal failure 1

Imaging Strategy:

• Perform thoracic ultrasound on every patient at initial presentation (detects >20 mL fluid, identifies nodularity suggesting malignancy) 1
• Chest radiography detects >175 mL on frontal view, >75 mL on lateral view 1
• If unsafe to aspirate or malignancy suspected, obtain CT chest/abdomen/pelvis; if malignancy unlikely, CT thorax with pleural contrast (venous phase) 1

Diagnostic Thoracentesis Decision Algorithm

Do NOT sample if:

• Clinical picture clearly suggests transudate (bilateral effusions with heart failure, cirrhosis, dialysis, hypoalbuminemia) AND
• Chest radiograph confirms the diagnosis AND
• No atypical features present 1

DO sample if:

• Unilateral effusion 1
• Atypical features present 1
• Transudate fails to respond to treatment 1
• Any suspicion of infection, malignancy, or pulmonary embolism 1
• Effusion thickness >10 mm on ultrasound 1

Thoracentesis Procedure

Technique:

• Use image-guided (ultrasound) thoracentesis for all patients to reduce complications 2
• Perform with 21-gauge needle and 50 mL syringe 1, 2
• Collect minimum 25-50 mL when malignancy suspected (volumes <25 mL acceptable but reduce cytology sensitivity) 2

Sample Handling Priority:

• First: Inoculate 5-10 mL into aerobic and anaerobic blood culture bottles 2
• Then: Fill sterile vials for remaining tests 2

Mandatory Tests on ALL Samples:

• Protein and LDH (to distinguish transudate from exudate) 1, 2
• pH (in all non-purulent effusions when infection considered) 1, 2
• Cell count with differential 2
• Gram stain and aerobic/anaerobic cultures 1, 2
• AAFB stain and TB culture 1, 2
• Cytology (25-50 mL processed by direct smear and cell-block) 2

Visual Inspection:

• Note appearance (serous, blood-tinged, frankly bloody, purulent) and odor (unpleasant suggests anaerobic infection) 1, 2
• If turbid/milky: centrifuge—clear supernatant indicates empyema, turbid supernatant indicates chylothorax 1, 2
• If grossly bloody: measure haematocrit—>50% of peripheral blood haematocrit confirms hemothorax 1, 2

Fluid Analysis Interpretation

Transudate vs. Exudate:

• Protein <25 g/L with normal serum protein = transudate 2
• Protein >35 g/L = exudate 2
• Protein 25-35 g/L: apply Light's criteria 1, 2

Exudate Characteristics Requiring Specific Action:

Infected Effusion (Parapneumonic/Empyema):

• Frankly purulent or turbid/cloudy fluid → immediate chest tube drainage 1
• Organisms on Gram stain or culture (non-purulent fluid) → immediate chest tube drainage 1
• pH <7.2 → chest tube drainage required 1
• Parapneumonic effusions not meeting these criteria → antibiotics alone if clinical progress good 1
• Poor clinical progress on antibiotics alone → prompt chest tube drainage 1

Malignancy Indicators:

• Lymphocyte predominance (≥80%) suggests malignancy or tuberculosis 3
• Cytology detects only 60% of malignant effusions 1, 2
• Cytology especially insensitive for mesothelioma 2
• Ultrasound showing diaphragmatic/parietal pleural nodularity highly suggestive 1

Tuberculosis Indicators:

• Lymphocyte-predominant effusion with ADA >35 IU/L in high-prevalence settings supports TB 2
• Prioritize tissue sampling over fluid alone for culture and drug-sensitivity data 2

Further Investigation for Undiagnosed Effusions

If initial fluid analysis non-diagnostic:

• Reconsider diagnoses with specific treatments: TB, pulmonary embolism, lymphoma, IgG4 disease, chronic heart failure 1
• Obtain contrast-enhanced CT thorax with fluid present (better pleural visualization, identifies biopsy sites) 1, 2
• Refer to chest physician 1
• Obtain pleural tissue via ultrasound/CT-guided biopsy, closed pleural biopsy, or thoracoscopy 1, 2
• Send tissue for histology and TB culture with repeat pleural aspiration 1

Small Effusions (<10 mm on ultrasound):

• Observe with interval imaging 1
• Sample if enlarges 1
• Watchful waiting with interval CT scans appropriate for persistent small effusions 1

Critical Pitfalls to Avoid

• Never rely on pleural fluid analysis alone to diagnose pulmonary embolism—maintain high clinical suspicion based on pleuritic pain, small effusion size, and disproportionate dyspnea 1, 2
• Never accept negative cytology as excluding malignancy—only 60% sensitive, requires tissue biopsy if suspicion remains 1, 2
• Never perform small-volume repeat cytology for suspected mesothelioma—proceed directly to tissue biopsy 2
• Never delay chest tube drainage when pH <7.2, purulent fluid, or positive Gram stain/culture—these predict poor outcomes without drainage 1